Modulation of leukocyte infiltration and phenotype in microporous tissue engineering scaffolds via vector induced IL-10 expression

Biomaterials

Volumn 35, Issue 6, 2014, Pages 2024-2031

  Gower, R Michael ^a   Boehler, Ryan M ^a   Azarin, Samira M ^a   Ricci, Christine F ^a   Leonard, Joshua N ^a,b,c   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Flow cytometry; Gene therapy; Immunomodulation; Inflammation; Leukocyte; Scaffold

Indexed keywords

BIOMATERIAL IMPLANTATION; BIOMATERIAL SCAFFOLDS; IMMUNO MODULATIONS; INFLAMMATION; INFLAMMATORY RESPONSE; LEUKOCYTE; TISSUE ENGINEERING SCAFFOLD; TRANSGENE EXPRESSION;

CELL ADHESION; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER; MACROPHAGES; PATHOLOGY; SCAFFOLDS; TISSUE;

SCAFFOLDS (BIOLOGY);

GAMMA INTERFERON; INTERLEUKIN 10; LENTIVIRUS VECTOR; POLYGLACTIN; TISSUE SCAFFOLD; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMPLANTATION; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE ENGINEERING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

FLOW CYTOMETRY; GENE THERAPY; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE; SCAFFOLD;

ANIMALS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC THERAPY; IMMUNOMODULATION; INTERLEUKIN-10; LEUKOCYTES; MALE; MICE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84890171096     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.036     Document Type: Article

References (42)

1. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
2. Jones K.S. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol 2008, 20:130-136.
3. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388.
4. Lopez-Armada M.J., Sanchez-Pernaute O., Largo R., Diez-Ortego I., Palacios I., Egido J., et al. Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis 2002, 61:1027-1030.
5. Gonzalez R., Glaser J., Liu M.T., Lane T.E., Keirstead H.S. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 2003, 184:456-463.
6. Brodbeck W.G., Voskerician G., Ziats N.P., Nakayama Y., Matsuda T., Anderson J.M. Invivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. JBiomed Mater Res A 2003, 64:320-329.
7. Gretzer C., Emanuelsson L., Liljensten E., Thomsen P. The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. JBiomater Sci Polym Ed 2006, 17:669-687.
8. Broughton G., Janis J.E., Attinger C.E. The basic science of wound healing. Plast Reconstr Surg 2006, 117:12S-34S.
9. Wood K.J., Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012, 93:1-10.
10. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
11. Holladay C., Power K., Sefton M., O'Brien T., Gallagher W.M., Pandit A. Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells invivo. Mol Ther 2011, 19:969-978.
12. Hong Y.S., Laks H., Cui G., Chong T., Sen L. Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. JHeart Lung Transplant 2002, 21:1188-1200.
13. Dudler J., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation 2006, 82:1733-1737.
14. Montane J., Bischoff L., Soukhatcheva G., Dai D.L., Hardenberg G., Levings M.K., et al. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. JClin Invest 2011, 121:3024-3028.
15. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034.
16. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.Y., Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
17. Jang J.H., Houchin T.L., Shea L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004, 1:127-138.
18. Aviles M.O., Lin C.H., Zelivyanskaya M., Graham J.G., Boehler R.M., Messersmith P.B., et al. The contribution of plasmid design and release to invivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials 2010, 31:1140-1147.
19. Aviles M.O., Shea L.D. Hydrogels to modulate lentivirus delivery invivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res 2011, 1:91-101.
20. Boehler R.M., Shin S., Fast A.G., Gower R.M., Shea L.D. APLG/HAp composite scaffold for lentivirus delivery. Biomaterials 2013, 34:5431-5438.
21. Holladay C.A., Duffy A.M., Chen X., Sefton M.V., O'Brien T.D., Pandit A.S. Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold. Biomaterials 2012, 33:1303-1314.
22. Miyoshi H., Blomer U., Takahashi M., Gage F.H., Verma I.M. Development of a self-inactivating lentivirus vector. JVirol 1998, 72:8150-8157.
23. Jang J.H., Rives C.B., Shea L.D. Plasmid delivery invivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther 2005, 12:475-483.
24. Rives C.B., des Rieux A., Zelivyanskaya M., Stock S.R., Lowe W.L., Shea L.D. Layered PLG scaffolds for invivo plasmid delivery. Biomaterials 2009, 30:394-401.
25. Blomeier H., Zhang X., Rives C., Brissova M., Hughes E., Baker M., et al. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation 2006, 82:452-459.
26. Graham J.G., Zhang X., Goodman A., Pothoven K., Houlihan J., Wang S., et al. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. Tissue Eng Part A 2013, 19:1465-1475.
27. Gibly R.F., Zhang X., Graham M.L., Hering B.J., Kaufman D.B., Lowe W.L., et al. Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models. Biomaterials 2011, 32:9677-9684.
28. Salvay D.M., Rives C.B., Zhang X., Chen F., Kaufman D.B., Lowe W.L., et al. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation 2008, 85:1456-1464.
29. van der Windt D.J., Echeverri G.J., Ijzermans J.N., Cooper D.K. The choice of anatomical site for islet transplantation. Cell Transplant 2008, 17:1005-1014.
30. Salvay D.M., Zelivyanskaya M., Shea L.D. Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds. Gene Ther 2010, 17:1134-1141.
31. McNally A.K., Jones J.A., Macewan S.R., Colton E., Anderson J.M. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. JBiomed Mater Res A 2008, 86:535-543.
32. Jenney C.R., Anderson J.M. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. JBiomed Mater Res 2000, 49:435-447.
33. Wisniewski N., Moussy F., Reichert W.M. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000, 366:611-621.
34. Rossi L., Migliavacca B., Pierige F., Serafini S., Sanvito F., Olivieri S., et al. Prolonged isletallograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes. Transplantation 2008, 85:648-650.
35. Kaufman D.B., Platt J.L., Rabe F.L., Dunn D.L., Bach F.H., Sutherland D.E. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of isletallografts. JExp Med 1990, 172:291-302.
36. Bottino R., Fernandez L.A., Ricordi C., Lehmann R., Tsan M.F., Oliver R., et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998, 47:316-323.
37. Li S., Li B., Jiang H., Wang Y., Qu M., Duan H., et al. Macrophage depletion impairs corneal wound healing after autologous transplantation in mice. PLoS One 2013, 8:e61799.
38. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007, 170:818-829.
39. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
40. Hidalgo L.G., Halloran P.F. Role of IFN-gamma in allograft rejection. Crit Rev Immunol 2002, 22:317-349.
41. Staples K.J., Smallie T., Williams L.M., Foey A., Burke B., Foxwell B.M., et al. IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3. JImmunol 2007, 178:4779-4785.
42. Tuinstra H.M., Aviles M.O., Shin S., Holland S.J., Zelivyanskaya M.L., Fast A.G., et al. Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials 2012, 33:1618-1626.